A Hematological-Related Prognostic Scoring System for Patients With Newly Diagnosed Glioblastoma

BACKGROUND: Glioblastoma is the most common primary malignant brain tumor. Recent studies have shown that hematological biomarkers have become a powerful tool for predicting the prognosis of patients with cancer. However, most studies have only investigated the prognostic value of unilateral hematol...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chao, Li, Long-Qing, Yang, Feng-Dong, Wei, Ruo-Lun, Wang, Min-Kai, Song, Di-Xiang, Guo, Xiao-Yue, Du, Wei, Wei, Xin-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758450/
https://www.ncbi.nlm.nih.gov/pubmed/33363021
http://dx.doi.org/10.3389/fonc.2020.591352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758450/
https://www.ncbi.nlm.nih.gov/pubmed/33363021
http://dx.doi.org/10.3389/fonc.2020.591352

Ejemplares similares